Advertisement
Advertisement
Catalent, Inc. (CTLT)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 12:40PM EDT. Market open.
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 98.18 |
| Open | 97.59 |
| Bid | 97.79 x 900 |
| Ask | 97.93 x 1000 |
| Day's Range | 96.94 - 99.63 |
| 52 Week Range | 86.34 - 142.64 |
| Volume | |
| Avg. Volume | 1,310,158 |
| Market Cap | 16.72B |
| Beta (5Y Monthly) | 1.34 |
| PE Ratio (TTM) | 30.74 |
| EPS (TTM) | 3.18 |
| Earnings Date | Jan 31, 2022 - Feb 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 159.46 |
- Simply Wall St.
Catalent (NYSE:CTLT) stock performs better than its underlying earnings growth over last five years
It might be of some concern to shareholders to see the Catalent, Inc. ( NYSE:CTLT ) share price down 11% in the last...
- Benzinga
Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook
View more earnings on CTLTSee more from BenzingaWhy Erytech Pharma Are Shares Moving Higher TodayDon't miss real-time alerts on your stocks - joinBenzinga Profor free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- Zacks
Catalent (CTLT) Q3 Earnings Beat Estimates, FY22 View Up
Catalent's (CTLT) robust performance across most of its segments drives its third-quarter fiscal 2022 top line.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
